GPP
NDRM

Great Point Partners’s NeuroDerm Ltd. Ordinary Shares NDRM Stock Holding History

Great Point Partners’s Portfolio NDRM Stock Details NDRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-311,000
Closed -$9.3M – 50
2017
Q2 		$9.3M Sell
311,000
-3,724
-1% -$96.5K 1.67% 20
2017
Q1 		$8.36M Buy
+314,724
New +$7.8M 1.66% 20

Other funds holding NDRM

AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
SAM
Sandell Asset Management New York $179M AUM 65.55% 1-Year Est. Return
OP
Omni Partners London, United Kingdom $2.03B AUM 126.33% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
OAM
Oxford Asset Management Oxford, United Kingdom $232M AUM 31% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
CFIC
City Financial Investment Company London, United Kingdom $562M AUM 5.93% 1-Year Est. Return
WIC
Water Island Capital New York $896M AUM 107.59% 1-Year Est. Return
FTCM
First Trust Capital Management Chicago, Illinois $1.9B AUM 58.39% 1-Year Est. Return

Great Point Partners's NDRM Position: Q3 2017 in Review

Great Point Partners sold out of NeuroDerm Ltd. Ordinary Shares (NDRM) in Q3 2017, closing a stake of 311,000 shares — an estimated $9.3M sold.

Great Point Partners first reported a position in NDRM in Q1 2017 and held it in 2 quarters. The position peaked at $9.3M in Q2 2017. 81 funds tracked by Wall St. Rank hold NDRM as of Q3 2017.

  • Great Point Partners reported no remaining NeuroDerm Ltd. Ordinary Shares position as of Q3 2017 after selling out during the quarter.
  • Great Point Partners sold 311,000 NeuroDerm Ltd. Ordinary Shares shares in Q3 2017, an estimated $9.3M.
  • Great Point Partners first reported a position in NeuroDerm Ltd. Ordinary Shares in Q1 2017 and held it in 2 quarters.
  • Great Point Partners's NeuroDerm Ltd. Ordinary Shares position peaked at $9.3M in Q2 2017.
  • 81 funds tracked by Wall St. Rank held NeuroDerm Ltd. Ordinary Shares as of Q3 2017.

Based on Great Point Partners's 13F filing for Q3 2017, filed 14 Nov 2017.